Support Alert

Class 4 medicines defect information: Xonvea 10 mg/10 mg gastro-resistant tablets

Alliance Pharmaceuticals Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that there are possible side effects not reported on the Patient Information Leaflet (PIL).

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society